MVision’s Guideline-Based AI Segmentation is Available in the EduCase Platform

Helsinki – 19th of January, 2022 – MVision AI, the leading provider of the guideline-based solution, collaborates with EduCase, the global leader in web-based education designed to support contouring skill instructions for radiation oncologists. EduCase is a computer-based training tool developed by RadOnc eLearning Center, LLC., to assist the development of structure segmentation (contouring) skills of radiation oncologists, medical physicists, and dosimetrists. 

The educational collaboration entitles EduCase to include MVision’s guideline-compliant AI segmentation, GCAIS™, software in all teaching sessions. This supplements students with hands-on experience working with MVision’s state-of-the-art solution. The MVisionaries will support EduCase to help educate the students, providing them with the unique opportunity to work with our groundbreaking AI models. 

“We are excited to be working with and delivering this new EdTech feature by integrating MVision’s AI segmentation guideline structures into the EduCase contour training platform. We are seeing significant demand in AI training in radiotherapy, and its impact and influence on the  educational ecosystem of Radiation Oncology, Contouring, and Education.” said Scott Kaylor: Co-Founder of EduCase

“Advancements of AI in Radiotherapy are redefining the role of clinicians. Education and training are becoming essential for clinicians to deliver high-quality treatment. Through our collaboration with EduCase, MVision is very excited to bring AI models to the EduCase platform to further accelerate the adoption of this novel technology” said Mahmudul Hasan: Co-Founder and CEO of MVision AI 

Discover EduCase



Are you eager to explore GCAIS™? Request a demo here. 

MVision AI is active on LinkedIn, Twitter, Facebook, and Instagram. Follow us on social media and subscribe to our newsletter to stay up-to-date on the latest MVision AI news.

Welcome you to contact MVision AI:

c/o Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland.

Tel: +358 (0) 40 5489 229



For media inquiries:

Tel: +358 40 500 7915


Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts


World Cancer Day – Joining efforts for a better cancer care

World cancer day, celebrated on the 4th of February, was established more than 20 years ago. It represents an initiative of the Union for International Cancer Control (UICC) , the oldest and largest global membership organization dedicated to taking action on cancer. UICC has over 1150 member organizations in 172…



How can AI-based auto-contouring improve the life of patients who need palliative radiation therapy?

Cancer is one of the leading causes of morbidity and death, worldwide. Approximately 18 million people are diagnosed with cancer each year and the number is expected to increase. Pain is experienced by two thirds of patients having advanced, metastatic or terminal disease (1). Other symptoms caused by compression on…



MVision AI Announces Partnership with Medron Medical Systems (Canada)

HELSINKI, Finland - January 22, 2024 MVision AI, a premier software service provider of GBS™ (Guideline-Based Segmentation) solution for same-day radiotherapy treatment planning, proudly announces a new distribution partnership with Medron Medical Systems, a leading health equipment provider in Canada. This collaboration follows the receipt of Medical Device License (MDL)…

Press Releases